336 related articles for article (PubMed ID: 26333366)
21. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial.
Wojnicz R; Nowak J; Szyguła-Jurkiewicz B; Wilczek K; Lekston A; Trzeciak P; Nowalany-Kozielska E; Zembala M; Wodniecki J; Poloński L
Am Heart J; 2006 Oct; 152(4):713.e1-7. PubMed ID: 16996844
[TBL] [Abstract][Full Text] [Related]
23. Autologous transplantation of bone marrow adult stem cells for the treatment of idiopathic dilated cardiomyopathy.
Westphal RJ; Bueno RR; Galvão PB; Zanis Neto J; Souza JM; Guérios ÊE; Senegaglia AC; Brofman PR; Pasquini R; Cunha CL
Arq Bras Cardiol; 2014 Dec; 103(6):521-9. PubMed ID: 25590932
[TBL] [Abstract][Full Text] [Related]
24. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
[TBL] [Abstract][Full Text] [Related]
25. Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial.
Ribeiro Dos Santos R; Rassi S; Feitosa G; Grecco OT; Rassi A; da Cunha AB; de Carvalho VB; Guarita-Souza LC; de Oliveira W; Tura BR; Soares MB; Campos de Carvalho AC;
Circulation; 2012 May; 125(20):2454-61. PubMed ID: 22523306
[TBL] [Abstract][Full Text] [Related]
26. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats.
Mao C; Hou X; Wang B; Chi J; Jiang Y; Zhang C; Li Z
Stem Cell Res Ther; 2017 Jan; 8(1):18. PubMed ID: 28129792
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
28. Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy.
Miettinen JA; Ylitalo K; Hedberg P; Jokelainen J; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
Heart; 2010 Mar; 96(5):362-7. PubMed ID: 19910293
[TBL] [Abstract][Full Text] [Related]
29. Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy.
Lezaic L; Socan A; Poglajen G; Peitl PK; Sever M; Cukjati M; Cernelc P; Wu JC; Haddad F; Vrtovec B
J Card Fail; 2015 Feb; 21(2):145-52. PubMed ID: 25459687
[TBL] [Abstract][Full Text] [Related]
30. The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease.
Mozid AM; Jones D; Arnous S; Saunders N; Wragg A; Martin J; Agrawal S; Mathur A
Stem Cells Dev; 2013 Jan; 22(2):216-23. PubMed ID: 22834565
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.
Vrtovec B; Sever M; Jensterle M; Poglajen G; Janez A; Kravos N; Zemljic G; Cukjati M; Cernelc P; Haddad F; Wu JC; Jorde UP
Stem Cells Transl Med; 2016 May; 5(5):632-8. PubMed ID: 27025690
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
33. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
34. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
Kang HJ; Kim HS; Zhang SY; Park KW; Cho HJ; Koo BK; Kim YJ; Soo Lee D; Sohn DW; Han KS; Oh BH; Lee MM; Park YB
Lancet; 2004 Mar; 363(9411):751-6. PubMed ID: 15016484
[TBL] [Abstract][Full Text] [Related]
35. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Socan A; Domanovic D; Cernelc P; Torre-Amione G; Haddad F; Wu JC
Circulation; 2013 Sep; 128(11 Suppl 1):S42-9. PubMed ID: 24030420
[TBL] [Abstract][Full Text] [Related]
36. [Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with dilated cardiomyopathy].
CHEN Y; GAO EM; GAO CY; XU Y; HUANG KJ; NIU ZM; ZHU ZY; YANG HH; LI MW
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1087-91. PubMed ID: 19134276
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure--Feasibility, safety and effects on exercise tolerance and cardiac function.
Hüttmann A; Dührsen U; Stypmann J; Noppeney R; Nückel H; Neumann T; Gutersohn A; Nikol S; Erbel R
Basic Res Cardiol; 2006 Jan; 101(1):78-86. PubMed ID: 16237506
[TBL] [Abstract][Full Text] [Related]
38. CD34
Frljak S; Jaklic M; Zemljic G; Cerar A; Poglajen G; Vrtovec B
Stem Cells Transl Med; 2018 Feb; 7(2):168-172. PubMed ID: 29380563
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.
Nso N; Bookani KR; Enoru ST; Radparvar F; Gordon R
Heart Fail Rev; 2022 May; 27(3):811-820. PubMed ID: 33587248
[TBL] [Abstract][Full Text] [Related]
40. [Long-term results of intracoronary transplantation of autologous bone marrow cells in dilated cardiomyopathy].
Bartolucci J; Verdugo FJ; Carrion F; Abarzúa E; Goset C; Lamich R; Sanhueza P; Pedreros P; Nazzal C; Khoury M; Figueroa FE
Rev Med Chil; 2015 Apr; 143(4):415-23. PubMed ID: 26204531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
